SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-22-013919 to MDxHealth SA (MDXH) (CIK 0001872529) (MDXH)

MDxHealth SA (MDXH) (CIK 0001872529)
Date: Dec. 27, 2022 · CIK: 0001872529 · Accession: 0000000000-22-013919

AI Filing Summary & Sentiment

File numbers found in text: 333-268885

Date
December 27, 2022
Author
Not clearly detected
Form
UPLOAD
Company
MDxHealth SA (MDXH) (CIK 0001872529)

Letter

United States securities and exchange commission logo December 27, 2022 Michael McGarrity Chief Executive Officer MDxHealth SA CAP Business Center Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium Re:MDxHealth SA Registration Statement on Form S-1 Filed December 19, 2022 File No. 333-268885 Dear Michael McGarrity: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jordan Nimitz at 202-551-5831 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text
United States securities and exchange commission logo
December 27, 2022
Michael McGarrity
Chief Executive Officer
MDxHealth SA
CAP Business Center
Zone Industrielle des Hauts-Sarts
4040 Herstal, Belgium
Re:MDxHealth SA
Registration Statement on Form S-1
Filed December 19, 2022
File No. 333-268885
Dear Michael McGarrity:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jordan Nimitz at 202-551-5831 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services